Bill

Bill > S0116


FL S0116

FL S0116
Prescription Insulin Drugs


summary

Introduced
08/07/2019
In Committee
08/16/2019
Crossed Over
Passed
Dead
03/14/2020

Introduced Session

2020 Regular Session

Bill Summary

Defining the term "prescription insulin drug"; requiring individual and group health insurance policies, respectively, to cap an insured's monthly cost-sharing obligation for covered prescription insulin drugs at a specified amount; requiring health benefit plans covering small employers to comply with such requirement; requiring health maintenance contracts to cap a subscriber's monthly cost-sharing obligation for covered prescription insulin drugs at a specified amount, etc.

AI Summary

This bill defines the term "prescription insulin drug" and requires individual and group health insurance policies, as well as health maintenance contracts, to cap an insured's or subscriber's monthly cost-sharing obligation for covered prescription insulin drugs at $100 per 30-day supply, regardless of the amount or type of insulin needed. The bill also requires health benefit plans covering small employers to comply with the cost-sharing cap. The bill allows insurers and health maintenance organizations to reduce the cost-sharing obligation by an amount greater than the specified cap, and grants the Florida Commission the authority to adopt rules to administer the provisions of the bill, which is set to take effect on January 1, 2021.

Committee Categories

Budget and Finance, Business and Industry

Sponsors (4)

Other Sponsors (1)

Banking and Insurance (Senate)

Last Action

Died in Appropriations Subcommittee on Agriculture, Environment, and General Government (on 03/14/2020)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...